CLOs on the Move

Minnesota Visiting Nurse Agency

www.mvna.org

 
Minnesota Visiting Nurse Agency is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mvna.org
  • 3433 Broadway St NE Ste 300
    Minneapolis, MN USA 55413
  • Phone: 612.617.4600

Executives

Name Title Contact Details

Similar Companies

Meta Dental Co

Meta Dental Co is a Elmhurst, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orbit Health

Digital Health Information Management provider for Sub-Saharan Africa.

Tower Health

Tower Health brings together more than 11,000 team members, 2,000 nationally recognized physicians, specialists and providers across 65 convenient locations.

Eidetik Inc

Eidetik Inc is a Uniontown, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.